Delivery Order SPE2DB22D9353-SPE2DB25FX2CP
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $26K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The contract, effective August 12, 2025 with completion by August 13, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $42,546.46 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) under a firm fixed-price contract type. This delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a time-sensitive pharmaceutical procurement with no set-aside designation applied. The products will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025. This firm fixed-price delivery order, valued at $43,113.50, represents a single procurement action under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $50,885.64 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price contract is classified as a delivery order with an ultimate completion date of September 11, 2025, and carries no set-aside designation. The work will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters as a woman-owned small business...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-unit quantity) on August 15, 2025. This firm fixed-price delivery order, which is set to be completed by August 18, 2025, represents a specific purchase order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). This award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, and the product will be delivered to Park Ridge,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award represents a single delivery order issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency on August 25, 2025, for the supply of Xtandi 40 mg capsules (120-count). The contract carries no set-aside designation and is scheduled for completion by August 26, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The delivery order, issued on July 16, 2025, with an ultimate completion date of July 17, 2025, carries firm fixed-price terms and represents a direct procurement with no set-aside designation. This award falls under DMS Pharmaceutical Group's...